Qiagen N.V Mergers and Acquisitions Summary

Life Science Company

Qiagen N.V has acquired 16 companies of its own, including 4 in the last 5 years. A total of 5 acquisitions came from private equity firms. It has also divested 1 asset.

Qiagen N.V’s largest acquisition to date was in 2020, when it acquired NeuMoDx Molecular for $248M. Qiagen N.V has acquired in 7 different US states, and 5 countries. The Company’s most targeted sectors include life science (43%) and information technology (22%).

Join Mergr and gain access to Qiagen N.V’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.

M&A Summary

  • M&A Total Activity15
    • M&A Buy Activity14
    • M&A Sell Activity1
  • Total Sectors Invested 5
  • Total Countries Invested 5
  • M&A Buy/Sell Connections 7
  • M&A Advisors 1

Qiagen N.V

Hulsterweg 82,
Venlo, 5912 PL
Netherlands,
+31 77 355 6600
www.qiagen.com

QIAGEN N.V. is a Netherlands holding company publically traded on NASDAQ and Frankfurt Prime Standard. The Company is the leading global provider of Sample & Assay Technologies that are used to transform biological materials into valuable molecular insights. Sample technologies are used to isolate and process DNA, RNA and proteins from biological samples such as blood or tissue. Assay technologies are then used to make these isolated biomolecules visible and ready for interpretation. QIAGEN markets more than 500 products around the world, selling both consumable kits and automation systems to customers through four customer classes: Molecular Diagnostics (human healthcare), Applied Testing (forensics, veterinary testing and food safety), Pharma (pharmaceutical and biotechnology companies) and Academia (life sciences research). Qiagen was founded in 1986 and is based in Venlo, the Netherlands.


M&A Summary

Buy vs Sell

Year ≤ '16 '17 '18 '19 '20 '21 T
Buy (0.8/yr) # 10 1 1 1 1 - 14
vol $433M $191M $248M $872M
Sell (0.2/yr) # - - - - 1 - 1
  15

Most Recent M&A

Company Date Value Type
NeuMoDx Molecular, Inc. 2020-09-17 248M USD Add-on Acquisition
Ann Arbor, Michigan · www.neumodx.com
NeXtal Biotechnologies 2020-01-08 - Divestiture
Holland, Ohio · www.nextalbiotech.com
N-of-One, Inc. 2019-01-07 - Add-on Acquisition
Concord, Massachusetts · www.n-of-one.com
STAT-Dx Life S.L. 2018-01-31 191M USD Add-on Acquisition
Barcelona, Spain · www.stat-dx.com
OmicSoft Corp. 2017-01-09 - Add-on Acquisition
Cary, North Carolina · www.omicsoft.com
Enzymatics, Inc. 2014-12-16 - Add-on Acquisition
Beverly, Massachusetts · www.enzymatics.com
Biobase GmbH 2014-05-21 - Add-on Acquisition
Wolfenbuettel, Germany · www.biobase.de
Ingenuity Systems, Inc. 2013-04-29 105M USD Add-on Acquisition
Redwood City, California · www.ingenuity.com
SABiosciences Corp. 2009-12-14 - Add-on Acquisition
Frederick, Maryland
DxS Ltd. 2009-09-22 130M USD Add-on Acquisition
Manchester, United Kingdom · www.dxsdiagnostics.com
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 6 (43%) 341M (39%) 1 (100%) -
Information Technology 3 (21%) 106M (12%) - -
Medical Products 3 (21%) 295M (34%) - -
Healthcare Services 1 (7%) 130M (15%) - -
Software 1 (7%) - - -
Total 14 $872M 1 -

By Geo

State/Country Buy Value Sell Value
United States 10 485M 1 -
  California 3 146M - -
  Massachusetts 2 - - -
  Maryland 1 - - -
  North Carolina 1 - - -
  Minnesota 1 38M - -
  Michigan 1 248M - -
  Ohio - - 1 -
Australia 1 66M - -
Germany 1 - - -
Spain 1 191M - -
United Kingdom 1 130M - -
Domestic - - - -
Cross-border 14 (100%) 872M (100%) 1 (100%) -
Total 14 $872M 1 -

Top M&A Advisors

Financial Deals
Jefferies LLC
1

Deal Values

buy # Total
$100M to $1B 4 $674M
< $100M 5 $198M
TOTAL $872M
Largest NeuMoDx Molecular, Inc.
$248M (2020-09-17)

M&A Connections

Deals
Acquired from
Investor(s)
21%
3 (21%)
Strategic(s)
7%
1 (7%)
Divested to
Strategic(s)
100%
1 (100%)

 Subscribe to unlock this and 166,937
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.2K Private Equity Firms
  • 156K M&A Transactions
  • 163K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.3K M&A Advisors
    (Investment Banks and Law Firms)
  • 55K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related list for Qiagen N.V

Life Science Companies , Netherlands Companies